Akebia Therapeutics | AKBA - Current Liabilities


Akebia Therapeutics reported $173.88M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 305.52M 28.41M Mar/2026
Agios Pharmaceuticals USD 58.84M 23.36M Mar/2026
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alnylam Pharmaceuticals USD 1.35B 116.87M Mar/2026
Amgen USD 24.96B 534M Mar/2026
Ardelyx USD 109.57M 20.96M Mar/2026
Astellas Pharma JPY 1.22T 106.19B Mar/2026
AstraZeneca USD 32.57B 1.95B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Exelixis USD 370.98M 34.67M Mar/2026
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Ionis Pharmaceuticals USD 717M 66M Mar/2026
Ironwood Pharmaceuticals USD 236.31M 5.91M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Lexicon Pharmaceuticals USD 9.9M 10.97M Mar/2026
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 2.4B 408M Mar/2026
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 186K 2.26M Jun/2025
Pharma Mar EUR 89.23M 4.65M Mar/2026
Prothena USD 32.52M 8.33M Mar/2026
PTC Therapeutics USD 923.6M 44.82M Mar/2026
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 5.11B 739.3M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
Vanda Pharmaceuticals USD 145.16M 27.29M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026